Table 3

Recent studies outlining benefit for statin use in sepsis

AuthorType of studySettingOutcome for statin group
van de Garde118Retrospective case–controlUK General Practice Research DatabaseOR 0.51 for pneumonia
Almog and colleagues6Prospective observationalAtherosclerosis patients from tertiary centreRR 0.22 for death from infection
Gupta and colleagues47Prospective observationalDialysis patients from national registryIRR 0.41 for hospital admission for sepsis
Donnino and colleagues34Prospective observationalEmergency Department attendees from tertiary centreOR 0.44 for death from infection
Frost and colleagues39Prospective observational case–controlCombined HMO databasesOR 0.49 for fatal pneumonia
Schlienger and colleagues109Retrospective case–controlUK National General Practice Research DatabaseOR 0.47 for fatal pneumonia
AuthorType of studySettingOutcome for statin group
van de Garde118Retrospective case–controlUK General Practice Research DatabaseOR 0.51 for pneumonia
Almog and colleagues6Prospective observationalAtherosclerosis patients from tertiary centreRR 0.22 for death from infection
Gupta and colleagues47Prospective observationalDialysis patients from national registryIRR 0.41 for hospital admission for sepsis
Donnino and colleagues34Prospective observationalEmergency Department attendees from tertiary centreOR 0.44 for death from infection
Frost and colleagues39Prospective observational case–controlCombined HMO databasesOR 0.49 for fatal pneumonia
Schlienger and colleagues109Retrospective case–controlUK National General Practice Research DatabaseOR 0.47 for fatal pneumonia
Table 3

Recent studies outlining benefit for statin use in sepsis

AuthorType of studySettingOutcome for statin group
van de Garde118Retrospective case–controlUK General Practice Research DatabaseOR 0.51 for pneumonia
Almog and colleagues6Prospective observationalAtherosclerosis patients from tertiary centreRR 0.22 for death from infection
Gupta and colleagues47Prospective observationalDialysis patients from national registryIRR 0.41 for hospital admission for sepsis
Donnino and colleagues34Prospective observationalEmergency Department attendees from tertiary centreOR 0.44 for death from infection
Frost and colleagues39Prospective observational case–controlCombined HMO databasesOR 0.49 for fatal pneumonia
Schlienger and colleagues109Retrospective case–controlUK National General Practice Research DatabaseOR 0.47 for fatal pneumonia
AuthorType of studySettingOutcome for statin group
van de Garde118Retrospective case–controlUK General Practice Research DatabaseOR 0.51 for pneumonia
Almog and colleagues6Prospective observationalAtherosclerosis patients from tertiary centreRR 0.22 for death from infection
Gupta and colleagues47Prospective observationalDialysis patients from national registryIRR 0.41 for hospital admission for sepsis
Donnino and colleagues34Prospective observationalEmergency Department attendees from tertiary centreOR 0.44 for death from infection
Frost and colleagues39Prospective observational case–controlCombined HMO databasesOR 0.49 for fatal pneumonia
Schlienger and colleagues109Retrospective case–controlUK National General Practice Research DatabaseOR 0.47 for fatal pneumonia
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close